1. Gastrointestinal tumor markers can be used for diagnosis, staging, prognosis, monitoring treatment, and detecting cancer recurrence. However, they lack specificity and sensitivity for early-stage cancers.
2. CEA is the most useful marker for colorectal cancer, correlating with disease stage and prognosis. It can detect recurrence earlier than other methods but lacks sensitivity for early-stage disease.
3. CA19-9 is the best marker for pancreatic cancer but lacks sensitivity for early tumors. It and other markers are not proven for prognosis or monitoring.
1. The document discusses carcinoma of the head of the pancreas, including its epidemiology, risk factors, pathology, clinical features, imaging, staging, and surgical management via the Whipple procedure.
2. It provides details of the Whipple procedure, including exposing and dissecting key structures like the superior mesenteric vein, Kocher maneuver, dividing vessels like the gastroduodenal artery, and transecting the stomach and jejunum.
3. The Whipple procedure involves a pancreaticoduodenectomy to resect the pancreatic head tumors while preserving stomach, duodenum, common bile duct, and pancreas.
Pancreatic neoplasms can be either solid tumors like adenocarcinomas or cystic neoplasms. Pancreatic adenocarcinoma has an extremely low 5-year survival rate of only 6% and is usually diagnosed at an advanced stage. Risk factors include smoking, chronic pancreatitis, diabetes and family history. Imaging tests like CT, MRI and EUS are used to stage the cancer and determine resectability. Surgical resection through a pancreatoduodenectomy or distal pancreatectomy offers the only chance for cure if the cancer is localized.
Acs0509 Tumors Of The Pancreas, Biliary Tract, And Liver 2009medbookonline
1) The document discusses tumors of the pancreas, biliary tract, and liver. It focuses on pancreatic ductal adenocarcinoma, which commonly presents with painless jaundice.
2) Diagnostic evaluation involves blood tests, imaging like CT or MRI to identify tumors and stage disease, and ERCP to visualize the biliary tree. Surgical resection is the main treatment if the tumor is resectable.
3) Challenges include determining resectability when tumors are atypical on imaging or small masses are not clearly identified. Additional tests like EUS may be needed in such cases to establish a diagnosis before deciding on surgical management.
This document summarizes the management of pancreatic carcinoma. It discusses the anatomy, epidemiology, risk factors, hereditary syndromes, pathophysiology including pre-cancerous lesions, types of pancreatic cancer, staging, prognostic factors, diagnostic techniques, treatment including surgery, chemotherapy, targeted therapy, radiotherapy and historical prospective studies. It provides a comprehensive overview of pancreatic carcinoma covering all relevant aspects of the disease.
Colon cancer is the fourth most commonly diagnosed cancer. About 70% of cases are sporadic, while 23% are genetic. It most commonly presents in the descending and sigmoid colon as a change in bowel habits with blood or mucus in the stool. Staging involves clinical exams, imaging like CT scans, and blood tests like CEA. Treatment depends on the stage, with surgery being the main treatment and chemotherapy sometimes used adjuvantly or palliatively. The 5-year survival ranges from 100% for stage 0 to 3-30% for stage 4 disease.
ROLE OF DIAGNOSTIC LAPROSCOPY IN ABDOMINAL MALIGNANCIES.pptxparikshithm1
Laparoscopy provides accurate diagnosis and staging of abdominal malignancies through direct visualization of the peritoneal cavity and organs. It can detect occult metastases that may be missed on imaging, avoiding unnecessary laparotomies in nonresectable cases. Laparoscopic ultrasound further enhances staging by allowing visualization of deeply located liver lesions and lymph nodes. For several cancer types including pancreatic and hepatobiliary malignancies, laparoscopy with ultrasound routinely changes management by identifying inoperable cases.
1. Gastrointestinal tumor markers can be used for diagnosis, staging, prognosis, monitoring treatment, and detecting cancer recurrence. However, they lack specificity and sensitivity for early-stage cancers.
2. CEA is the most useful marker for colorectal cancer, correlating with disease stage and prognosis. It can detect recurrence earlier than other methods but lacks sensitivity for early-stage disease.
3. CA19-9 is the best marker for pancreatic cancer but lacks sensitivity for early tumors. It and other markers are not proven for prognosis or monitoring.
1. The document discusses carcinoma of the head of the pancreas, including its epidemiology, risk factors, pathology, clinical features, imaging, staging, and surgical management via the Whipple procedure.
2. It provides details of the Whipple procedure, including exposing and dissecting key structures like the superior mesenteric vein, Kocher maneuver, dividing vessels like the gastroduodenal artery, and transecting the stomach and jejunum.
3. The Whipple procedure involves a pancreaticoduodenectomy to resect the pancreatic head tumors while preserving stomach, duodenum, common bile duct, and pancreas.
Pancreatic neoplasms can be either solid tumors like adenocarcinomas or cystic neoplasms. Pancreatic adenocarcinoma has an extremely low 5-year survival rate of only 6% and is usually diagnosed at an advanced stage. Risk factors include smoking, chronic pancreatitis, diabetes and family history. Imaging tests like CT, MRI and EUS are used to stage the cancer and determine resectability. Surgical resection through a pancreatoduodenectomy or distal pancreatectomy offers the only chance for cure if the cancer is localized.
Acs0509 Tumors Of The Pancreas, Biliary Tract, And Liver 2009medbookonline
1) The document discusses tumors of the pancreas, biliary tract, and liver. It focuses on pancreatic ductal adenocarcinoma, which commonly presents with painless jaundice.
2) Diagnostic evaluation involves blood tests, imaging like CT or MRI to identify tumors and stage disease, and ERCP to visualize the biliary tree. Surgical resection is the main treatment if the tumor is resectable.
3) Challenges include determining resectability when tumors are atypical on imaging or small masses are not clearly identified. Additional tests like EUS may be needed in such cases to establish a diagnosis before deciding on surgical management.
This document summarizes the management of pancreatic carcinoma. It discusses the anatomy, epidemiology, risk factors, hereditary syndromes, pathophysiology including pre-cancerous lesions, types of pancreatic cancer, staging, prognostic factors, diagnostic techniques, treatment including surgery, chemotherapy, targeted therapy, radiotherapy and historical prospective studies. It provides a comprehensive overview of pancreatic carcinoma covering all relevant aspects of the disease.
Colon cancer is the fourth most commonly diagnosed cancer. About 70% of cases are sporadic, while 23% are genetic. It most commonly presents in the descending and sigmoid colon as a change in bowel habits with blood or mucus in the stool. Staging involves clinical exams, imaging like CT scans, and blood tests like CEA. Treatment depends on the stage, with surgery being the main treatment and chemotherapy sometimes used adjuvantly or palliatively. The 5-year survival ranges from 100% for stage 0 to 3-30% for stage 4 disease.
ROLE OF DIAGNOSTIC LAPROSCOPY IN ABDOMINAL MALIGNANCIES.pptxparikshithm1
Laparoscopy provides accurate diagnosis and staging of abdominal malignancies through direct visualization of the peritoneal cavity and organs. It can detect occult metastases that may be missed on imaging, avoiding unnecessary laparotomies in nonresectable cases. Laparoscopic ultrasound further enhances staging by allowing visualization of deeply located liver lesions and lymph nodes. For several cancer types including pancreatic and hepatobiliary malignancies, laparoscopy with ultrasound routinely changes management by identifying inoperable cases.
This document discusses investigations for colorectal cancer including preliminary investigations like digital rectal exam and blood tests, imaging like colonoscopy, barium enema, CT colonography to detect the primary tumor and metastases. It also discusses using ultrasound and CT scans to evaluate for spread to liver, lungs and lymph nodes. The role of the CEA tumor marker in prognosis and surveillance is described.
This document provides information on carcinoma of the stomach, including:
- Risk factors include H. pylori infection, diet, genetics, smoking.
- Types include intestinal and diffuse. Staging uses TNM and other classifications.
- Common symptoms are weight loss, abdominal pain, vomiting. Investigations include endoscopy and biopsy.
- Treatment depends on stage but commonly includes surgery such as gastrectomy along with lymph node dissection. Endoscopic resection may be used for early stages. Adjuvant therapy is sometimes used for later stages.
Ca Pancreas is a systemic disease from the outset, with metastasis often present even after curative resection. Diagnosis typically occurs late, with only 5% of patients surviving 5 years. Imaging tools like CT, EUS, and MRI are used to determine resectability and stage the cancer. Biopsy and tumor markers help establish the diagnosis, while ERCP can provide palliative biliary stenting. Despite improved imaging, there are currently no effective screening strategies due to the disease's asymptomatic nature and non-specific presentation until late stages.
Laparoscopy and laparoscopic ultrasound improve staging of pancreatic cancer and help determine resectability, avoiding unnecessary surgery. Laparoscopic techniques can treat some benign and malignant pancreatic tumors, as well as pancreatic trauma, pseudocysts, and provide palliative bypass when cancer is unresectable, with benefits of less morbidity, mortality, and shorter hospital stays compared to open surgery.
Colorectal cancer is the second most common cause of cancer deaths in North America. Risk factors include family history, age over 50, inflammatory bowel disease, poor diet, smoking, and certain genetic conditions. Screening tools like fecal occult blood tests and colonoscopy can detect early-stage cancers. Treatment may involve surgery to remove the cancerous tissue, and sometimes chemotherapy or radiation. After treatment, regular follow-up via tests like CT scans and colonoscopies can help monitor for cancer recurrence.
Gall bladder carcinoma seen in Indian popluation most common in women and presents at a very late stage .Survival is in months hence palliative treatment is being preferred .
The document discusses anal canal carcinoma and its management. It covers the epidemiology, etiology, risk factors, carcinogenesis, morphology, clinical features, classification, screening, diagnosis, staging, treatment and recent advances of anal canal carcinoma. Screening and removing precancerous polyps is important for prevention. Diagnosis involves imaging and biopsy. Treatment depends on staging and may include surgery, chemotherapy and radiation. Ongoing research focuses on improved screening, staging and minimally invasive treatment options.
This document discusses pancreatic adenocarcinoma and assessing resectability with CT imaging. It provides background on pancreatic cancer and details CT findings that indicate:
1) The tumor is locally advanced and surrounds blood vessels, making it unresectable.
2) Distant metastases are present, such as small liver lesions typical of metastases or enlarged lymph nodes, also making the tumor unresectable.
3) Complete surgical resection, which offers the only chance of cure, requires that the tumor can be safely removed without involvement of nearby structures.
1. The document presents Italian consensus guidelines for the diagnostic workup and follow up of cystic pancreatic neoplasms (CPNs).
2. It provides 52 statements with evidence levels and recommendations on topics including clinical evaluation, imaging, endoscopic ultrasound, cyst fluid markers, and pathology.
3. The guidelines are intended to standardize the evaluation and management of CPNs according to morphology and symptoms, while taking into account resources in the Italian healthcare system.
This document provides an overview of gastric carcinoma, including:
- Causes of epigastric lumps that may indicate gastric carcinoma
- Risk factors like H. pylori infection, diet, smoking, and genetic factors
- Staging classifications including TNM, Lauren-Jarvi, and Borrmann systems
- Treatment approaches like endoscopic or surgical resection depending on stage, with lymph node dissection and reconstruction techniques described
- Adjuvant therapies including chemotherapy and radiation to improve survival
- 5-year survival rates are improved with neoadjuvant chemotherapy and adjuvant chemoradiation compared to surgery alone.
Esophagectomy : APPROACHES, CONTROVERSIES AND CURRENT EVIDENCEDr Amit Dangi
This document discusses esophagectomy, the surgical approaches for esophageal cancer resection. It covers the relevant anatomy, blood supply, lymph drainage, and histology of esophageal cancer. It then discusses pre-treatment evaluation including staging assessments and criteria for resection. The key surgical procedures for cervical, thoracic, and esophagogastric junction cancers are described including the transhiatal, Ivor-Lewis, and tri-incisional approaches. Post-operative outcomes from recent studies comparing these approaches are summarized.
This document discusses ampullary carcinomas, including their epidemiology, clinical manifestations, diagnosis, staging, treatment, and prognosis. It provides details on: the average age of diagnosis being 60-70 years old; the most common histologic subtype being intestinal (47%); obstructive jaundice being the most common presenting symptom (80%); diagnostic tests including ERCP, CT, and tumor markers; the TNM staging system; pancreaticoduodenectomy being the standard treatment for localized disease; and adjuvant therapy options including chemotherapy and chemoradiotherapy for stage IB or higher cancers.
Colorectal cancer is the second leading cause of cancer death in western countries. Early detection through screening can prevent over 50% of deaths, but screening rates remain low. Current noninvasive screening methods like fecal occult blood tests (FOBT) have limitations in sensitivity and specificity. Blood markers like CEA, LASA, and CA19-9 are not adequate screening tools. Stool markers show more promise, like immunochemical FOBT, colonocytes, and stool DNA testing which can detect mutations. While promising, stool DNA testing needs more research on cost effectiveness and patient acceptance before being recommended for general screening. Overall, no single marker is sufficient for screening and early detection remains a challenge.
Dr Ashutosh Mal presented information on colorectal cancer (CRC) management and recent updates. The presentation covered screening, staging, diagnosis, and treatment options for CRC including surgery, chemotherapy, targeted therapy, immunotherapy, and radiotherapy. Recent advances discussed were total mesorectal excision, sphincter-saving surgery techniques like the colonic J-pouch, laparoscopic colorectal surgery, colonic stenting for obstructing cancers, and transanal endoscopic microsurgery.
This document discusses the surgical aspects of stomach carcinoma. It covers signs and symptoms of early and advanced gastric cancer, classifications including pathological and clinical staging (TNM), investigations including endoscopy, CT scans, laparoscopy, and treatment options including endoscopic mucosal resection, surgical resection, and adjuvant/palliative therapies. Treatment depends on disease stage, with endoscopic resection for very early cancers, surgery with or without lymph node dissection for early cancers, and surgery plus adjuvant therapy for localized advanced cancers.
MR imaging is useful for staging prostate cancer once diagnosis is established through biopsy. It allows for identification of extracapsular extension, seminal vesicle invasion, and lymph node involvement. The departmental cases demonstrated various MRI findings of prostate cancer, including low T2 signal in the peripheral zone, restricted diffusion, and increased choline on MR spectroscopy. MRI is more sensitive and specific than other imaging modalities for local staging of prostate cancer when combined with MR spectroscopy.
Colon cancer can develop due to chromosomal instability or microsatellite instability. Presentation may be asymptomatic, or include changes in bowel habits, blood in stool, weight loss, or abdominal masses. Diagnosis involves tests such as colonoscopy, biopsy, and imaging. Treatment depends on stage and includes surgery to remove the cancerous section of colon as well as nearby lymph nodes, with the possibility of additional chemotherapy or radiation. Recurrence is common within the first few years and is monitored through cancer antigen testing, imaging and colonoscopy surveillance.
Hepatic carcinoma, also known as hepatocellular carcinoma (HCC), is one of the most common and deadly cancers worldwide, killing over 1 million people per year. Risk factors include hepatitis B and C infections, cirrhosis, alcohol use, and aflatoxin exposure. HCC typically presents in patients with cirrhosis as an asymptomatic liver mass and is diagnosed through blood tests showing elevated AFP levels and imaging exams like ultrasound, CT, or MRI. Treatment depends on the stage but may include surgical resection, liver transplantation, ablation procedures, embolization, or chemotherapy. Long-term surveillance after treatment is important for early detection of recurrence.
This document discusses a case of a 60-year-old male diagnosed with rectal cancer. It provides details on his medical history, including a sigmoidoscopy that revealed adenocarcinoma of the rectum. He received neoadjuvant chemoradiation therapy. The document discusses the clinical anatomy of the rectum, risk factors for rectal cancer, staging systems, diagnostic workup, and treatment options like surgery. The main treatment is surgery, with the goal of total mesorectal excision to reduce local recurrence rates.
Gallbladder cancer is an uncommon but highly fatal cancer. It is most often diagnosed in patients undergoing surgery for gallbladder stones. Over 90% of gallbladder cancer patients have gallstones or chronic gallbladder inflammation. Major risk factors include female sex, older age, obesity, smoking, and gallbladder diseases. Symptoms are often vague, and many cases are diagnosed late when the cancer has spread. Surgery offers the best chance of treatment when the cancer is localized, but palliative options are usually necessary for advanced cases. Prognosis remains very poor due to late diagnosis and limited effective therapies.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
More Related Content
Similar to Periampullary_carcinoma_–diagnosis_with_staging,_preoperative (2).pptx
This document discusses investigations for colorectal cancer including preliminary investigations like digital rectal exam and blood tests, imaging like colonoscopy, barium enema, CT colonography to detect the primary tumor and metastases. It also discusses using ultrasound and CT scans to evaluate for spread to liver, lungs and lymph nodes. The role of the CEA tumor marker in prognosis and surveillance is described.
This document provides information on carcinoma of the stomach, including:
- Risk factors include H. pylori infection, diet, genetics, smoking.
- Types include intestinal and diffuse. Staging uses TNM and other classifications.
- Common symptoms are weight loss, abdominal pain, vomiting. Investigations include endoscopy and biopsy.
- Treatment depends on stage but commonly includes surgery such as gastrectomy along with lymph node dissection. Endoscopic resection may be used for early stages. Adjuvant therapy is sometimes used for later stages.
Ca Pancreas is a systemic disease from the outset, with metastasis often present even after curative resection. Diagnosis typically occurs late, with only 5% of patients surviving 5 years. Imaging tools like CT, EUS, and MRI are used to determine resectability and stage the cancer. Biopsy and tumor markers help establish the diagnosis, while ERCP can provide palliative biliary stenting. Despite improved imaging, there are currently no effective screening strategies due to the disease's asymptomatic nature and non-specific presentation until late stages.
Laparoscopy and laparoscopic ultrasound improve staging of pancreatic cancer and help determine resectability, avoiding unnecessary surgery. Laparoscopic techniques can treat some benign and malignant pancreatic tumors, as well as pancreatic trauma, pseudocysts, and provide palliative bypass when cancer is unresectable, with benefits of less morbidity, mortality, and shorter hospital stays compared to open surgery.
Colorectal cancer is the second most common cause of cancer deaths in North America. Risk factors include family history, age over 50, inflammatory bowel disease, poor diet, smoking, and certain genetic conditions. Screening tools like fecal occult blood tests and colonoscopy can detect early-stage cancers. Treatment may involve surgery to remove the cancerous tissue, and sometimes chemotherapy or radiation. After treatment, regular follow-up via tests like CT scans and colonoscopies can help monitor for cancer recurrence.
Gall bladder carcinoma seen in Indian popluation most common in women and presents at a very late stage .Survival is in months hence palliative treatment is being preferred .
The document discusses anal canal carcinoma and its management. It covers the epidemiology, etiology, risk factors, carcinogenesis, morphology, clinical features, classification, screening, diagnosis, staging, treatment and recent advances of anal canal carcinoma. Screening and removing precancerous polyps is important for prevention. Diagnosis involves imaging and biopsy. Treatment depends on staging and may include surgery, chemotherapy and radiation. Ongoing research focuses on improved screening, staging and minimally invasive treatment options.
This document discusses pancreatic adenocarcinoma and assessing resectability with CT imaging. It provides background on pancreatic cancer and details CT findings that indicate:
1) The tumor is locally advanced and surrounds blood vessels, making it unresectable.
2) Distant metastases are present, such as small liver lesions typical of metastases or enlarged lymph nodes, also making the tumor unresectable.
3) Complete surgical resection, which offers the only chance of cure, requires that the tumor can be safely removed without involvement of nearby structures.
1. The document presents Italian consensus guidelines for the diagnostic workup and follow up of cystic pancreatic neoplasms (CPNs).
2. It provides 52 statements with evidence levels and recommendations on topics including clinical evaluation, imaging, endoscopic ultrasound, cyst fluid markers, and pathology.
3. The guidelines are intended to standardize the evaluation and management of CPNs according to morphology and symptoms, while taking into account resources in the Italian healthcare system.
This document provides an overview of gastric carcinoma, including:
- Causes of epigastric lumps that may indicate gastric carcinoma
- Risk factors like H. pylori infection, diet, smoking, and genetic factors
- Staging classifications including TNM, Lauren-Jarvi, and Borrmann systems
- Treatment approaches like endoscopic or surgical resection depending on stage, with lymph node dissection and reconstruction techniques described
- Adjuvant therapies including chemotherapy and radiation to improve survival
- 5-year survival rates are improved with neoadjuvant chemotherapy and adjuvant chemoradiation compared to surgery alone.
Esophagectomy : APPROACHES, CONTROVERSIES AND CURRENT EVIDENCEDr Amit Dangi
This document discusses esophagectomy, the surgical approaches for esophageal cancer resection. It covers the relevant anatomy, blood supply, lymph drainage, and histology of esophageal cancer. It then discusses pre-treatment evaluation including staging assessments and criteria for resection. The key surgical procedures for cervical, thoracic, and esophagogastric junction cancers are described including the transhiatal, Ivor-Lewis, and tri-incisional approaches. Post-operative outcomes from recent studies comparing these approaches are summarized.
This document discusses ampullary carcinomas, including their epidemiology, clinical manifestations, diagnosis, staging, treatment, and prognosis. It provides details on: the average age of diagnosis being 60-70 years old; the most common histologic subtype being intestinal (47%); obstructive jaundice being the most common presenting symptom (80%); diagnostic tests including ERCP, CT, and tumor markers; the TNM staging system; pancreaticoduodenectomy being the standard treatment for localized disease; and adjuvant therapy options including chemotherapy and chemoradiotherapy for stage IB or higher cancers.
Colorectal cancer is the second leading cause of cancer death in western countries. Early detection through screening can prevent over 50% of deaths, but screening rates remain low. Current noninvasive screening methods like fecal occult blood tests (FOBT) have limitations in sensitivity and specificity. Blood markers like CEA, LASA, and CA19-9 are not adequate screening tools. Stool markers show more promise, like immunochemical FOBT, colonocytes, and stool DNA testing which can detect mutations. While promising, stool DNA testing needs more research on cost effectiveness and patient acceptance before being recommended for general screening. Overall, no single marker is sufficient for screening and early detection remains a challenge.
Dr Ashutosh Mal presented information on colorectal cancer (CRC) management and recent updates. The presentation covered screening, staging, diagnosis, and treatment options for CRC including surgery, chemotherapy, targeted therapy, immunotherapy, and radiotherapy. Recent advances discussed were total mesorectal excision, sphincter-saving surgery techniques like the colonic J-pouch, laparoscopic colorectal surgery, colonic stenting for obstructing cancers, and transanal endoscopic microsurgery.
This document discusses the surgical aspects of stomach carcinoma. It covers signs and symptoms of early and advanced gastric cancer, classifications including pathological and clinical staging (TNM), investigations including endoscopy, CT scans, laparoscopy, and treatment options including endoscopic mucosal resection, surgical resection, and adjuvant/palliative therapies. Treatment depends on disease stage, with endoscopic resection for very early cancers, surgery with or without lymph node dissection for early cancers, and surgery plus adjuvant therapy for localized advanced cancers.
MR imaging is useful for staging prostate cancer once diagnosis is established through biopsy. It allows for identification of extracapsular extension, seminal vesicle invasion, and lymph node involvement. The departmental cases demonstrated various MRI findings of prostate cancer, including low T2 signal in the peripheral zone, restricted diffusion, and increased choline on MR spectroscopy. MRI is more sensitive and specific than other imaging modalities for local staging of prostate cancer when combined with MR spectroscopy.
Colon cancer can develop due to chromosomal instability or microsatellite instability. Presentation may be asymptomatic, or include changes in bowel habits, blood in stool, weight loss, or abdominal masses. Diagnosis involves tests such as colonoscopy, biopsy, and imaging. Treatment depends on stage and includes surgery to remove the cancerous section of colon as well as nearby lymph nodes, with the possibility of additional chemotherapy or radiation. Recurrence is common within the first few years and is monitored through cancer antigen testing, imaging and colonoscopy surveillance.
Hepatic carcinoma, also known as hepatocellular carcinoma (HCC), is one of the most common and deadly cancers worldwide, killing over 1 million people per year. Risk factors include hepatitis B and C infections, cirrhosis, alcohol use, and aflatoxin exposure. HCC typically presents in patients with cirrhosis as an asymptomatic liver mass and is diagnosed through blood tests showing elevated AFP levels and imaging exams like ultrasound, CT, or MRI. Treatment depends on the stage but may include surgical resection, liver transplantation, ablation procedures, embolization, or chemotherapy. Long-term surveillance after treatment is important for early detection of recurrence.
This document discusses a case of a 60-year-old male diagnosed with rectal cancer. It provides details on his medical history, including a sigmoidoscopy that revealed adenocarcinoma of the rectum. He received neoadjuvant chemoradiation therapy. The document discusses the clinical anatomy of the rectum, risk factors for rectal cancer, staging systems, diagnostic workup, and treatment options like surgery. The main treatment is surgery, with the goal of total mesorectal excision to reduce local recurrence rates.
Gallbladder cancer is an uncommon but highly fatal cancer. It is most often diagnosed in patients undergoing surgery for gallbladder stones. Over 90% of gallbladder cancer patients have gallstones or chronic gallbladder inflammation. Major risk factors include female sex, older age, obesity, smoking, and gallbladder diseases. Symptoms are often vague, and many cases are diagnosed late when the cancer has spread. Surgery offers the best chance of treatment when the cancer is localized, but palliative options are usually necessary for advanced cases. Prognosis remains very poor due to late diagnosis and limited effective therapies.
Similar to Periampullary_carcinoma_–diagnosis_with_staging,_preoperative (2).pptx (20)
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)GeorgeKieling1
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
Allopurinol, a uric acid synthesis inhibitor acts by inhibiting Xanthine oxidase competitively as well as non- competitively, Whereas Oxypurinol is a non-competitive inhibitor of xanthine oxidase.
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...Donc Test
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Applications of NMR in Protein Structure Prediction.pptxAnagha R Anil
This presentation explores the pivotal role of Nuclear Magnetic Resonance (NMR) spectroscopy in predicting protein structures. It delves into the methodologies, advancements, and applications of NMR in determining the three-dimensional configurations of proteins, which is crucial for understanding their function and interactions.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Fexofenadine is sold under the brand name Allegra.
It is a selective peripheral H1 blocker. It is classified as a second-generation antihistamine because it is less able to pass the blood–brain barrier and causes lesser sedation, as compared to first-generation antihistamines.
It is on the World Health Organization's List of Essential Medicines. Fexofenadine has been manufactured in generic form since 2011.
Selective alpha1 blockers are Prazosin, Terazosin, Doxazosin, Tamsulosin and Silodosin majorly used to treat BPH, also hypertension, PTSD, Raynaud's phenomenon, CHF
2. LABORATORY EVALUATION:
BASIC LABORATORY TESTING INCLUDE:
1)CBC
2)Electrolytes
3) Liver Function Tests
4) Albumin
5) Prothrombin time
SPECIAL LABORATORY TESTING:
1) CA19-9
SPECIFICITY And SENSITIVITY IS LIMITED And Poor PPV 72.3% ( Salvatore
Scara’ et al.adv Exp Med biol.2015) don't make it a good cancer specific
marker. Although with limitation CA19-9 continues being the only
pancreatic marker.
Not detected in Lewis A-B phenotype, falsely elevated in ongoing biliary
obstruction, Other conditions such as inflammation, cholangitis, and
nonpancreatic tumors (gastrointestinal, ovarian) are also associated with
increased CA 19-9 levels
3. IMAGING EVALUATION:
• A dedicated, fine-cut, 3phase pancreas protocol computed tomography
(CT) scan.
ARTERIAL PHASE (25 SEC) :HYPERVASCULAR NEUROENDOCINE TUMOURS
ARE BETTER SEEN.
PANCREATC PHASE(40 sec): Hypo vascular pancreatic adenocarcinoma are
better appreciated.
PORTAL VENOUS PHASE (70 SE): Vascular invasion liver mets are better
seen.
Why cect ?
1. Better delineation of pancreatic mass to vascular structures
2. Level of bile duct obstruction
3. Dilation of pancreatic duct
4. Regional lymph nodes
5. Liver or pelvic deposits
6. Presence of ascites
7. SN-86%
4. Axial and coronal computed
tomography scans
demonstrating a resectable
tumor in the head of the
pancreas (note plastic
biliary stent) with clear
tissue planes around the
superior mesenteric artery
and portal vein.
Magnetic resonance
cholangiopancreatography
demonstrating an abrupt cutoff in the
common bile duct from a tumor in the
head of the pancreas. The pancreatic
duct is also dilated, giving a strong
suspicion of malignancy
• In patients with CT contrast allergy- MRI with MRCP can be done.
sensitivity of 84 %
5. • ENDOSCOPIC ULTRASONOGRAPHY:
Small tumours > 2cm
Relationship of the tumour to vasculature may well be seen
Regional lymph nodes may also be seen
FNAC can be done with decreased potential for peritoneal seeding
compared to percutaneous biopsy
The sensitivity of EUS-FNA for diagnosing pancreatic cancer is in the
range of 80–95 %.
Before initatiating NAT.
Endoscopic ultrasound showing pancreatic mass with portal vein involvement.
6. ROLE OF ERCP VS MRCP:
• MRCP is preoperative imaging procedure of choice to evaluate the
pancreaticobiliary tree as it can evaluate the bile ducts both above and
below a stricture (as opposed to ERCP) with no loss of sensitivity.
• Distinguishes chronic focal pancreatitis with adenocarcinoma “duct
penetrating sign”
• Lesser morbidity (no radiation & no contrast)
• ERCP helps in tissue diagnosis and biliary decompression in advanced as
well borderline resectable cases undergoing NAT
Focal pancreatitis demonstrating
"duct penetrating" sign. Axial
SSFSE T2w image shows a hypo-
intense mass in the head of the
pancreas (arrow) (a). The MRCP
slab image shows a smooth
continuity of the pancreatic duct
(arrow) through the mass typical
of the "duct penetrating sign"
seen in focal pancreatitis (b).